BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $5.17 million. The enterprise value is $1.02 million.
Important Dates
The last earnings date was Tuesday, April 15, 2025, before market open.
Earnings Date | Apr 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BGLC has 1.80 million shares outstanding. The number of shares has increased by 12.24% in one year.
Current Share Class | 1.80M |
Shares Outstanding | 1.80M |
Shares Change (YoY) | +12.24% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 30.98% |
Owned by Institutions (%) | 0.99% |
Float | 1.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.54 |
Forward PS | n/a |
PB Ratio | 0.62 |
P/TBV Ratio | 0.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.11 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.81 |
Quick Ratio | 3.10 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -89.73 |
Financial Efficiency
Return on equity (ROE) is -17.78% and return on invested capital (ROIC) is -12.92%.
Return on Equity (ROE) | -17.78% |
Return on Assets (ROA) | -10.86% |
Return on Invested Capital (ROIC) | -12.92% |
Return on Capital Employed (ROCE) | -22.37% |
Revenue Per Employee | $317,022 |
Profits Per Employee | -$53,278 |
Employee Count | 30 |
Asset Turnover | 0.87 |
Inventory Turnover | 6.51 |
Taxes
In the past 12 months, BGLC has paid $3,494 in taxes.
Income Tax | 3,494 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.60% in the last 52 weeks. The beta is 1.76, so BGLC's price volatility has been higher than the market average.
Beta (5Y) | 1.76 |
52-Week Price Change | -51.60% |
50-Day Moving Average | 3.06 |
200-Day Moving Average | 3.65 |
Relative Strength Index (RSI) | 51.79 |
Average Volume (20 Days) | 1,758,806 |
Short Selling Information
The latest short interest is 291,486, so 16.22% of the outstanding shares have been sold short.
Short Interest | 291,486 |
Short Previous Month | 1.16M |
Short % of Shares Out | 16.22% |
Short % of Float | 23.51% |
Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, BGLC had revenue of $9.51 million and -$1.60 million in losses. Loss per share was -$0.90.
Revenue | 9.51M |
Gross Profit | 1.29M |
Operating Income | -1.90M |
Pretax Income | -2.64M |
Net Income | -1.60M |
EBITDA | -1.79M |
EBIT | -1.90M |
Loss Per Share | -$0.90 |
Full Income Statement Balance Sheet
The company has $4.38 million in cash and $227,731 in debt, giving a net cash position of $4.15 million or $2.31 per share.
Cash & Cash Equivalents | 4.38M |
Total Debt | 227,731 |
Net Cash | 4.15M |
Net Cash Per Share | $2.31 |
Equity (Book Value) | 8.32M |
Book Value Per Share | 4.63 |
Working Capital | 5.48M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.23 million and capital expenditures -$226,989, giving a free cash flow of -$2.46 million.
Operating Cash Flow | -2.23M |
Capital Expenditures | -226,989 |
Free Cash Flow | -2.46M |
FCF Per Share | -$1.37 |
Full Cash Flow Statement Margins
Gross margin is 13.56%, with operating and profit margins of -19.95% and -16.81%.
Gross Margin | 13.56% |
Operating Margin | -19.95% |
Pretax Margin | -16.77% |
Profit Margin | -16.81% |
EBITDA Margin | -18.85% |
EBIT Margin | -19.95% |
FCF Margin | n/a |